Case Fatality of Patients With Type 1 Diabetes After Myocard
This study aimed to evaluate the case fatality in patients with type 1 diabetes after MI. Case fatality was higher in patients with type 1 diabetes than in propensity score–matched controls without diabetes at 30 days (12.8% vs. 8.5%) and at 1 year (24.3% vs. 16.8%) after MI. Patients with type 1 diabetes had poorer prognosis in subgroups of men and women and of those with and without ST-elevation MI, with and without revascularization, with and without atrial fibrillation, and with and without heart failure. The relative fatality risk in type 1 diabetes was highest in younger patients. Older age, heart failure, peripheral vascular disease, renal failure, and no revascularization were associated with worse prognosis after MI. The case fatality among patients with type 1 diabetes decreased during the study period, but outcome differences compared with patients without diabetes remained similar.

Source: https://diabetesjournals.org/care/article/45/7/1657/147067/Case-Fatality-of-Patients-With-Type-1-Diabetes
Like
Comment
Share